SCHEMBL24019587

SCHEMBL24019587

CS(=O)(=O)Nc1ccc(C(O)CSc2nnnn2-c2ccc(C(=O)O)c(C3CC3)c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.39
▸ ALDH1A1 P00352 5/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ LMNA P02545 1/20 0.37
▸ TP53 P04637 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ MEN1 O00255 3/20 0.36
▸ TSHR P16473 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ MAPK1 P28482 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ ESR1 P03372 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21952011 0.85 LMNA (0.47) ALOX5ALDH1A1KMT2ALMNAHSD17B10
SCHEMBL28663116 0.84 TP53 (0.36) ALDH1A1KMT2ALMNATP53HSD17B10
SCHEMBL28659325 0.83 KMT2A (0.51) ALDH1A1KMT2ATP53HSD17B10MEN1
SCHEMBL31396222 0.75 ALPL (0.47) ALDH1A1KMT2ALMNAHSD17B10MEN1
SCHEMBL28673736 0.73 HPGD (0.53) ALDH1A1KMT2ATP53MEN1TSHR
SCHEMBL28670742 0.72 HPGD (0.50) ALDH1A1KMT2ATP53MEN1TSHR
SCHEMBL28664794 0.71 HPGD (0.49) ALDH1A1KMT2AMEN1POLBMAPK1
SCHEMBL21952069 0.70 ALDH1A1 (0.44) ALDH1A1KMT2ALMNATP53HSD17B10
SCHEMBL29798375 0.70 ALDH1A1 (0.44) ALDH1A1KMT2ALMNATP53HSD17B10
SCHEMBL28678932 0.70 TSHR (0.53) ALOX5ALDH1A1KMT2ALMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115768422-A Ubiquitin ligase inhibitors for the treatment of cancer 诺沃亚桑托斯教授基金会 2023-03-07 — — CN disclosed
CN-113677340-A Compounds that selectively and efficiently inhibit Hakai-mediated ubiquitination as anti-cancer agents 诺沃亚桑托斯教授基金会 2021-11-19 — — CN disclosed
EP-3909577-A1 UBIQUITIN-LIGASE INHIBITORS FOR THE TREATMENT OF CANCER Fundación Profesor Novoa Santos (ES) 2021-11-17 — — EP disclosed
Send feedback